AMRYT PHARMA PLC (AMYT)
Institutional ownership reported to the SEC as of Q2 2026, across 12 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
-66
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Global Frontier Investments LLC | $0 | 0 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 0 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 67 | $675.3M | 40,472,814 | 37 | 5 | 6 | 12.6% |
| Q4 2022 | 41 | $254.0M | 34,780,503 | 6 | 8 | 7 | 0.0% |
| Q3 2022 | 56 | $315.7M | 45,610,500 | 10 | 15 | 5 | 0.0% |
| Q2 2022 | 55 | $314.0M | 44,886,580 | 5 | 17 | 9 | 0.1% |
| Q1 2022 | 60 | $349.1M | 42,232,191 | 14 | 17 | 11 | 0.1% |
| Q4 2021 | 53 | $391.5M | 36,240,142 | 7 | 17 | 12 | 0.1% |
| Q3 2021 | 58 | $379.0M | 31,608,158 | 35 | 13 | 2 | 0.1% |
| Q2 2021 | 27 | $185.3M | 15,272,020 | 9 | 8 | 4 | 0.0% |
| Q1 2021 | 23 | $208.7M | 14,982,914 | 9 | 5 | 0 | 0.0% |
| Q4 2020 | 15 | $186.3M | 13,159,257 | 5 | 2 | 4 | 0.0% |
| Q3 2020 | 12 | $65.3M | 5,293,875 | 11 | 0 | 0 | 0.0% |